PARDI, Norbert
|
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.Nature, 543, 248-251, 2017.Prior to their development of the mRNA vaccine for Covid-19, Karikó and Weissman (Nobel Prize 2023) and colleagues used a novel mRNA vaccine, with base modifications created in their laboratory, to generate a protective Zika vaccine. From the abstract: “....Here we demonstrate that a single low-dose intradermal immunization with lipid nanoparticle-encapsulated nucleoside modified mRNA (mRNA-LPN), encoding the pre-membrane and envelope glycoproteins of a strain from the ZIKV outbreak in 2013, elicited potent and durable neutralizing antibody responses in mice and non-human primates....” In 2023 the full text of this paper was available from nature.com at this link. Subjects: INFECTIOUS DISEASE › VECTOR-BORNE DISEASES › Mosquito-Borne Diseases › Zika Virus Disease, VIROLOGY › VIRUSES (by Family) › Flaviviridae › Zika Virus |